Clinical phenotypes of COPD: identification, definition and implications for guidelines
Marc Miravitlles1, Myriam Calle, Juan José Soler-Cataluña
1Institut d'Investigacions Biomèdiques August Pi i Sunyer, Ciber de Enfermedades Respiratorias, Hospital Clínic, Barcelona, Spain. marcm@separ.es
Archivos De Bronconeumologia
|December 27, 2011
Summary
Understanding COPD phenotypes like the exacerbator, overlap COPD-asthma, and emphysema is key for personalized treatment. Identifying these distinct patient profiles guides therapy selection for better outcomes.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Therapeutics
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous condition with varying clinical presentations and treatment responses.
- Phenotyping COPD aims to categorize patients based on distinct clinical attributes for improved management.
- Three key phenotypes—exacerbator, overlap COPD-asthma, and emphysema—demonstrate differential prognoses and therapeutic sensitivities.
Purpose of the Study:
- To define and differentiate key COPD phenotypes.
- To elucidate the distinct characteristics and treatment responses of exacerbator, overlap COPD-asthma, and emphysema phenotypes.
- To highlight the importance of phenotype identification for personalized COPD management.
Main Methods:
- Review and synthesis of existing literature on COPD phenotypes.
- Clinical characterization of exacerbator, overlap COPD-asthma, and emphysema phenotypes.
- Analysis of treatment responses based on identified phenotypes.
Main Results:
- The exacerbator phenotype is characterized by frequent exacerbations and may require anti-inflammatory drugs alongside bronchodilators.
- The overlap COPD-asthma phenotype exhibits airflow variability and incomplete reversibility, responding well to inhaled corticosteroids and bronchodilators.
- The emphysema phenotype shows limited response to anti-inflammatory drugs, with bronchodilators and rehabilitation being primary treatments.
Conclusions:
- Phenotypic classification of COPD is crucial for tailoring treatment strategies.
- Personalized medicine in COPD necessitates understanding individual patient characteristics and disease severity.
- Targeted therapies based on COPD phenotypes can optimize clinical outcomes and patient management.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...